CNS Pharmaceuticals (CNSP) announced a 1-for-12 reverse split of its common stock. Beginning on July 22, 2025, the Company’s common stock will continue to trade on The Nasdaq Capital Market on a split adjusted basis under the trading symbol “CNSP” but will trade under the following new CUSIP number: 18978H508.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNSP: